Why Revenue Growth Can Coincide With a Lower Company Valuation
A company can grow revenue and still lose enterprise value as its valuation multiple falls. Boards need to weigh that risk against the case for waiting.
Higher revenue doesn’t guarantee a higher enterprise value. For founders weighing whether to sell or keep building, the valuation multiple can fall enough to outweigh operating growth—and a bigger business may ultimately command a lower price.
That tension came into focus in a conversation with a company founder who saw room for further growth over the next couple of years and hoped to reach a larger exit. The company was doing well, but the decision to wait rested on an assumption worth testing: that growth would translate into more value for its owners.
Growth can be overtaken by a falling multiple
Consider the hypothetical SaaS business in the source example. At $15 million in annual recurring revenue (ARR) and a valuation of 6x ARR, its implied enterprise value is $90 million. Two years later, ARR has grown to $20 million, but the multiple has fallen to 3.5x revenue. The implied value is then $70 million. Revenue is up 33%, while enterprise value is down 22%.
The figures are illustrative. Their point is the relationship between the two measures: the value of a company depends on more than the amount of revenue it generates. When buyers apply a lower multiple, operating growth may not be enough to preserve enterprise value.
That distinction matters when a founder sets a future revenue target as the reason to defer a sale. The target may be reached while the market’s view of the business changes. If the multiple contracts during that period, the company could be larger and still be valued below its earlier level. The revenue milestone alone can’t settle whether waiting has paid off.
Buyers weigh more than the headline number
A revenue multiple reflects a mix of company-specific qualities and financial results. Buyers may examine management depth, how dependent the business is on its founder, competitive pressure, product differentiation and the company’s strategic relevance to potential acquirers. These attributes shape how durable buyers think the business will be and how readily it could fit into their plans.
They also consider absolute financial measures, including revenue, EBITDA and cash flow. Relative measures add another layer: growth rates, margins, net revenue retention and gross revenue retention. Retention percentages matter because they help show whether customers stay, spend more or leave. Buyers tend to assess these figures together and compare them with relevant peers.
As a company matures, its revenue and profits can rise even as its growth rate slows. That combination may lead buyers to see less room for expansion, depending on the company’s other strengths. Stronger profitability, better retention or a more capable management team may support the valuation; weakening growth or heavier founder dependence may weigh on it. The effect comes from the full picture, not a single metric.
For a board, that calls for regular discussion of which company characteristics are improving and which could erode over the coming year. It also means asking how prospective buyers might interpret those changes. The operating plan and the valuation case should be reviewed together.
Prepare while the business has options
A sale takes time. Preparation, buyer conversations, negotiation and due diligence all give potential buyers opportunities to reassess the company’s performance and forecasts. If a slowdown is already visible when the process begins, buyers may question whether projections still hold, which can weaken the seller’s position.
Buyer interest also has its own timetable. A particular technology, customer base or geographic presence may be valuable to a strategic buyer at one point. That interest can change after the buyer launches an internal product, acquires a competitor or revises its spending priorities. A company can’t assume that a buyer’s interest will remain constant while it pursues another growth target.
Waiting can still make sense when additional scale attracts more buyers, margins improve or customer concentration declines. Those possibilities should be made concrete in the board’s analysis. One approach is to compare estimated enterprise value across scenarios in which revenue grows while the multiple stays steady, rises or falls. Each case makes clear how much the outcome depends on operating progress and how much depends on the buyer’s valuation.
Enterprise value is also not the same as the amount shareholders ultimately receive. Debt, cash, dilution, liquidation preferences and transaction terms can affect proceeds. Those details belong in the comparison alongside the headline valuation, particularly when a proposed growth plan comes with costs, financing needs or changes to ownership.
No one can reliably identify the peak valuation in advance. But choosing to wait still embeds a view about how the company’s results and its multiple will change. Boards can make that view explicit by tracking enterprise value alongside revenue and testing what would have to be true for a delay to create more value.
Itay Sagie is a guest contributor to Crunchbase News, a lecturer and strategic adviser to startups and investors specializing in strategy, growth and M&A. Connect with him on LinkedIn.
Related Crunchbase query
Illustration: Dom Guzman
